Drug profile · INN
alogliptin + metformin
NESINA MET 12.5/850
alogliptin + metformin (NESINA MET 12.5/850) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — alogliptin + metformin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
alogliptin + metformin (NESINA MET 12.5/850) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is alogliptin + metformin?
alogliptin + metformin (NESINA MET 12.5/850) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for alogliptin + metformin?
NESINA MET 12.5/850 is a marketed brand name for alogliptin + metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.